Navigation Links
Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
Date:4/21/2009

products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in Forest Laboratories' Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and any subsequent SEC filings.

                    FOREST LABORATORIES, INC. AND SUBSIDIARIES
                        CONSOLIDATED STATEMENTS OF INCOME


                                        THREE MONTHS         TWELVE MONTHS
                                       ENDED MARCH 31       ENDED MARCH 31
                                      2009      2008       2009       2008
                                   (In thousands, except per share amounts)

    Revenues:
      Net sales                    $896,726  $898,703 $3,636,055 $3,501,802
      Contract revenue               55,203    60,105    209,000    216,500

      Interest income                12,751    31,148     74,409    108,680

      Other income                      797       897      3,318      9,347

    Net revenues                    965,477   990,853  3,922,782  3,836,329


    Costs and expenses:
      Cost of goods sold            207,684   210,376    816,680    800,114
      Selling, general and
       Administrative               515,090   327,426  1,474,274  1,154,845
    Research and development        123,774   255,081    661,294    670,973
                                    846,548   792,883  2,952,248  2,625,932

    Income before

    income tax expense              118,929   197,970    970,534  1,210,397

      Income tax expense             26,166    25,200    202,791    242,464

    Net income                      $92,763  $172,770   $767,743   $967,933


    Net income per share:
      Basic                           $0.31     $0.55      $2.53      $3.08
      Diluted                         $0.31     $0.55      $2.52      $3.06


    Weighted average number of
     shares outstanding:
      Basic                     
'/>"/>
SOURCE Forest Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
3. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
4. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
5. German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
6. Wake Forest Baptist and Rivulet Connect New Operating Rooms with Interactive Video
7. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
8. Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
9. United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
10. Old-Growth Forests Dying Off in U.S. West
11. Forest Laboratories, Inc. Reports Q309 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Schmidt ... of Tanya De La Paz. , Schmidt National Law Group, a leading firm ... District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates for ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... Consumer Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, ... hazardous waste handling rules constantly evolving in the consumer goods industry, it can ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily ... to explore, revitalize and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager ... Seasons Resort Maui, the island’s only Forbes Five Star resort and Travel + Leisure’s ...
(Date:9/4/2015)... Portland, ME (PRWEB) , ... September 04, 2015 ... ... Symposium focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 ... ihsymposium.com/focus-event. , Speakers at the 2015 symposium are doctors and researchers at the ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... pale in comparison to settlements under the Stark physician self-referral law. “Stark ... Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail which deals ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... B1) states that a deficiency in vitamin B1 could ... treat obesity//. This is based on a study published ... of Neurology. ,The study further elucidates ... Wernicke’s encephalopathy, a severe neurological condition. ,Women ...
... or sell Viagra, as they fear it may result in ... ,"We will not sale the drug as it may lead ... problems," said Amar Sinha, general secretary of the Jharkhand Chemist ... added: "The common practice here is to sell medicines even ...
... Resorts has banned smoking in the rooms, restaurants, bars and ... and the Caribbean from January 2006//., ,Guests will only ... areas. , ,Westin said research among its customers had ... , ,"Nobody likes to walk into a smoky guest ...
... an Arizona-based biotech company is testing out OraTest, its detection ... is a disfiguring entity // that is caused by chewing ... that nearly 30,000 people are diagnosed with oral cancer every ... into perspective when he said, "We are subduing the dangers ...
... at the Picower Institute for Learning and Memory shows that neurons ... earlier concept of adult brain // lacks the capacity to grow ... avenues to research on the various techniques that could induce growth ... like the genetic or the sensory or by other ways that ...
... conducted by Crimmins and Finch showed the effect of ... of developing cardiovascular diseases // . ,They ... Sweden, France, England and Switzerland from different years but ... 1900 modern medicine was an important factor in treating ...
Cached Medicine News:Health News:More The Usage More The Growth In The Adult Brain. 2
(Date:9/4/2015)... 04, 2015 Research ... addition of the "Pharmacovigilance (London, UK - ... Understanding PhV today - the principles ... in Drug safety. This course aims ... pharmacovigilance. New entrants as well as experienced operators ...
(Date:9/4/2015)... , Sep. 04, 2015 ... ) has announced the addition of the ... Market, 2010-2019" report to their offering. ... polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. ... and cartilage matrix, sodium hyaluronate can lubricate ...
(Date:9/3/2015)... Report Details Ovarian Cancer ... Changes and Emerging Opportunities What,s the future for ... study forecasts those pharmaceutical revenues. There you find ... also explore trends, results, treatments, R&D, and opportunities, ... predictions to 2025 at overall world market, submarket, ...
Breaking Medicine Technology:Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2Investigation Report on China's Sodium Hyaluronate Market 2015 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6
... 23, 2011 ViewRay™, Inc., a privately held ... clearance for its radiotherapy treatment planning and delivery ... the company,s new radiation therapy system, which combines ... in the late stages of development, the integrated ...
... Inc. (Nasdaq: NBIX ) announced today that Kevin ... be presenting at Citi,s 2011 Global Health Care Conference in ... place on Tuesday, March 1, 2011 at 2:00 p.m. Eastern ... webcast and may be accessed on the Company,s website at ...
Cached Medicine Technology:ViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: